TD Waterhouse Canada’s Elevance Health ELV Stock Holding History

TD Waterhouse Canada’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.4M	Sell	22,598 -13,150	-37%	-$4.88M	0.02%	296
2026 Q1	$10.7M	Buy	35,748 +28,992	+429%	+$9.53M	0.03%	265
2025 Q4	$2.37M	Sell	6,756 -1,644	-20%	-$556K	0.01%	418
2025 Q3	$2.8M	Buy	8,400 +2,748	+49%	+$855K	0.02%	388
2025 Q2	$2.52M	Sell	5,652 -15,642	-73%	-$6.29M	0.02%	394
2025 Q1	$9.22M	Buy	21,294 +4,678	+28%	+$1.88M	0.08%	194
2024 Q4	$6.13M	Buy	16,616 +46	+0.3%	+$19.2K	0.05%	236
2024 Q3	$8.47M	Buy	16,570 +1,110	+7%	+$593K	0.07%	201
2024 Q2	$8.26M	Buy	15,460 +173	+1%	+$91.4K	0.07%	192
2024 Q1	$7.69M	Buy	+15,287	New	+$7.6M	0.06%	207

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

TD Waterhouse Canada's ELV Position: Q2 2026 in Review

TD Waterhouse Canada reduced its Elevance Health (ELV) stake by 37% in Q2 2026, selling an estimated $4.88M and leaving 22,598 shares worth $9.4M. The position accounts for 0.02% of the portfolio, ranked #296.

TD Waterhouse Canada first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. The position peaked at $10.7M in Q1 2026. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

TD Waterhouse Canada held 22,598 shares of Elevance Health worth $9.4M as of Q2 2026.
TD Waterhouse Canada sold 13,150 Elevance Health shares in Q2 2026, an estimated $4.88M.
Elevance Health made up 0.02% of TD Waterhouse Canada's portfolio in Q2 2026, its #296 holding.
TD Waterhouse Canada first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
TD Waterhouse Canada's Elevance Health position peaked at $10.7M in Q1 2026.
917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.